RENSSELAER, NY ·
OSHA Inspection: REGENERON PHARMACEUTICALS INC.
Complaint inspection · Health discipline
At a glance
On , OSHA opened a complaint health inspection of REGENERON PHARMACEUTICALS INC. in 81 COLUMBIA TURNPIKE, RENSSELAER, NY 12144 (NAICS 325412). OSHA activity number 311981088.
OSHA opens inspections for many reasons: routine scheduling under a national or local emphasis program, an employee complaint or referral, or a follow-up after a reported injury. Opening or conducting an inspection is not itself an allegation or a finding that this employer broke any rule; any findings appear as the citations listed below, and citations can be contested, reduced, or withdrawn.
Where did this inspection happen?
- Establishment
- REGENERON PHARMACEUTICALS INC.
- Site address
- 81 COLUMBIA TURNPIKE
- City
- RENSSELAER
- State
- NY
- ZIP
- 12144
What kind of inspection was it?
- Inspection type
- Complaint (B)
- Scope
- Partial (B)
- Discipline
- Health
- Advance notice
- No
- Union status
- Non-union (N)
When did the case open and close?
- Opened
- Closing conference
- Case closed
- Last modified
- Data loaded
Establishment context
- NAICS code
- 325412
- SIC code (legacy)
- 2834
- Employees
- 250
- Ownership type
- Private (A)
Citations
3 citations on file for this inspection.
1910.146 C05 IIC
- Issued
- Feb 26, 2010
- Abate by
- Mar 11, 2010
- Penalty
- Initial $1,125 · Current $1,125
1910.151 C
- Issued
- Feb 26, 2010
- Abate by
- Mar 16, 2010
- Penalty
- Initial $3,500 · Current $3,500
1910.134 C01
- Issued
- Feb 26, 2010
- Abate by
- Mar 11, 2010
More inspections at Regeneron Pharmaceuticals INC.
View Regeneron Pharmaceuticals INC.'s full OSHA safety record →
More inspections in this industry (NAICS 325412)
More inspections in NY
Source
This record is reproduced from the U.S. Department of Labor Open Data API (OSHA inspection dataset). OSHA publishes its own view of this case as inspection number 311981088.
Look up any company's OSHA accident reports by company, or browse severe injury reports by year, state, and company.